Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 9, 2011The Lancet OncologyOpen Access

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJack CuzickGSGregory P. SwansonGFGabrielle Fisher

Discussion

Loading...

Member takes

Overview

Retrospective study demonstrates prognostic utility of a cell cycle gene signature in prostate cancer, highlighting improved risk assessment.

Key Points

  • Evaluate the prognostic value of an RNA expression signature derived from cell cycle proliferation genes in individuals diagnosed with prostate cancer.
  • Retrospective analysis investigating RNA expression levels of cell cycle proliferation genes in prostate cancer patient samples.
  • The cell cycle proliferation gene expression signature provides significant prognostic information regarding clinical outcomes in prostate cancer.

Cite This Study

Cuzick et al. (2011) studied this question.

synapsesocial.com/papers/69d850d5f4e559c61eae36fbhttps://doi.org/10.1016/s1470-2045(10)70295-3
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Unveiling Prognostic RNA Biomarkers through a Multi-Cohort Study in Colorectal Cancer2024 · 7 citations
  2. 2Integrative bioinformatics approach yields a novel gene expression risk model for prognosis and progression prediction in prostate cancer2024 · 2 citations
  3. 3Development and verification of cell cycle-related gene markers for prognosis in bladder cancer2026
  4. 4Single‐Cell and Bulk RNA Sequencing Highlights Intra‐Tumoral Heterogeneity and Malignant Progression Mechanisms in Prostate Cancer2025 · 2 citations
  5. 5Identification and verification of exosome-related gene signature to predict the cancer status and prognosis of prostate cancer2025 · 3 citations